119 related articles for article (PubMed ID: 16752636)
1. [Decision on the immunomodulating therapy in unspecific osteomyelitis of the spine].
Vishnevskiĭ AA; Orlov AB; Tikhodeev SA
Vestn Khir Im I I Grek; 2006; 165(2):32-6. PubMed ID: 16752636
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of the immuological status in patients with nonspecific spinal osteomyelitis].
Vishnevskiĭ AA; Orlov AB
Vestn Khir Im I I Grek; 2004; 163(5):73-7. PubMed ID: 15651700
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of thymalin in the treatment of patients with traumatic osteomyelitis of the lower jaw].
Kozlov VA; Kotov GA; Tsimbalistov AV; Khavinson VKh; Morozov VG
Vestn Khir Im I I Grek; 1981 Dec; 127(12):3-6. PubMed ID: 6978564
[No Abstract] [Full Text] [Related]
4. Does Acute placement of instrumentation in the treatment of vertebral osteomyelitis predispose to recurrent infection: long-term follow-up in immune-suppressed patients.
Carragee E; Iezza A
Spine (Phila Pa 1976); 2008 Sep; 33(19):2089-93. PubMed ID: 18758365
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of vertebral osteomyelitis with recombinant human bone morphogenetic protein-2.
O'Shaughnessy BA; Kuklo TR; Ondra SL
Spine (Phila Pa 1976); 2008 Mar; 33(5):E132-9. PubMed ID: 18317180
[TBL] [Abstract][Full Text] [Related]
6. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
Karachunskiĭ MA; Gergert VIa; Iakovleva OB
Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
[TBL] [Abstract][Full Text] [Related]
7. Optimal duration of antibiotic therapy in vertebral osteomyelitis.
Roblot F; Besnier JM; Juhel L; Vidal C; Ragot S; Bastides F; Le Moal G; Godet C; Mulleman D; Azaïs I; Becq-Giraudon B; Choutet P
Semin Arthritis Rheum; 2007 Apr; 36(5):269-77. PubMed ID: 17207522
[TBL] [Abstract][Full Text] [Related]
8. [Effect of glucocorticosteroids on the immunological indices of diffuse toxic goiter patients].
Epishin AV
Vrach Delo; 1984 Jul; (7):41-3. PubMed ID: 6332424
[No Abstract] [Full Text] [Related]
9. [Specific complaints and pain syndrome in nonspecific osteomyelitis of the spine].
Vishnevskiĭ AA
Vestn Khir Im I I Grek; 2007; 166(6):26-31. PubMed ID: 18411737
[TBL] [Abstract][Full Text] [Related]
10. [T- and B-cellular immunity system in thyrotoxicosis patients treated with thyrostatic preparations].
Kabatsiĭ NP
Vrach Delo; 1984 Feb; (2):80-2. PubMed ID: 6202062
[No Abstract] [Full Text] [Related]
11. [Cellular immunity factors in traumatic osteomyelitis of the mandible].
Zuev VP; Litvinov VI
Stomatologiia (Mosk); 1981; 60(3):42-4. PubMed ID: 6973839
[No Abstract] [Full Text] [Related]
12. [Basic indicators of cellular immunity in patients with chronic staphylococcal osteomyelitis].
Pudil R; Karpas K; Hanovcová I
Acta Chir Orthop Traumatol Cech; 1993; 60(2):100-3. PubMed ID: 8342372
[TBL] [Abstract][Full Text] [Related]
13. [Immunomodulating activity of thymogen in acute pancreatitis].
Saĭdakhmedova ZT
Vopr Pitan; 2000; 69(6):35-6. PubMed ID: 11452372
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic significance of typical immune reactions in myocardial infarction].
Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications].
Bulava GV; Nikulina VP
Khirurgiia (Mosk); 1996; (2):104-7. PubMed ID: 8754918
[TBL] [Abstract][Full Text] [Related]
16. [The state of immunity in patients with hematogenous osteomyelitis of the spine and femur (comparative characteristics)].
Fishchenko VIa; Dizik GM
Ortop Travmatol Protez; 1988 Sep; (9):29-32. PubMed ID: 3211538
[No Abstract] [Full Text] [Related]
17. Evaluation of thin needle aspiration biopsy in the diagnosis and management of vertebral osteomyelitis (VO).
Hassoun A; Taur Y; Singer C
Int J Infect Dis; 2006 Nov; 10(6):486-7. PubMed ID: 16876453
[No Abstract] [Full Text] [Related]
18. Pyogenic infection of the spine. A review of twenty-eight cases.
Griffiths HE; Jones DM
J Bone Joint Surg Br; 1971 Aug; 53(3):383-91. PubMed ID: 5562365
[No Abstract] [Full Text] [Related]
19. Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?
Buser A; Stern M; Arber C; Medinger M; Halter J; Rovo A; Favre G; Lohri A; Tichelli A; Gratwohl A
Bone Marrow Transplant; 2008 Oct; 42(7):483-7. PubMed ID: 18695668
[TBL] [Abstract][Full Text] [Related]
20. [Changes in the immunological reactivity of patients with disseminated sclerosis treated by prednisolone and the preparation Proper-Myl].
Iarosh AA; Macheret EL; Iarosh AA; Zapadniuk BV
Vrach Delo; 1990 Feb; (2):83-6. PubMed ID: 2339565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
